iBio (IBIO) Net Income (2010 - 2026)

iBio (IBIO) has 17 years of Net Income data on file, last reported at -$7.8 million in Q1 2026.

• On a quarterly basis, Net Income fell 58.63% year-over-year to -$7.8 million in Q1 2026; TTM through Mar 2026 was -$27.8 million, a 54.9% decrease from a year earlier, with the FY2025 full-year figure at -$81.6 million, down 761.76% from the prior year.
• Net Income for Q1 2026 stood at -$7.8 million, up from -$9.1 million in the prior quarter.
• Over the last five years, Net Income for IBIO reached as high as -$537000.0 in Q1 2024 and fell as low as -$23.0 million in Q4 2022.
• Historically, Net Income has averaged -$5.8 million across 5 years, with a median of -$4.9 million in 2025.
• Across the five-year window, Net Income soared 93.66% in 2023 and sank 821.42% in 2025, its largest moves.
• Year by year, Net Income stood at -$23.0 million in 2022, then jumped by 83.81% to -$3.7 million in 2023, then dropped by 19.47% to -$4.4 million in 2024, then tumbled by 104.43% to -$9.1 million in 2025, then climbed by 13.68% to -$7.8 million in 2026.
• Per Business Quant data, the three most recent Net Income figures were -$7.8 million in Q1 2026, -$9.1 million in Q4 2025, and -$5.7 million in Q3 2025.